Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
9,841
+2,314
+31% +$261K 0.2% 79
2025
Q4
$943K Buy
7,527
+283
+4% +$36.1K 0.19% 75
2025
Q3
$970K Buy
7,244
+90
+1% +$11.8K 0.21% 60
2025
Q2
$973K Sell
7,154
-23
-0.3% -$3.03K 0.23% 61
2025
Q1
$952K Sell
7,177
-325
-4% -$41.4K 0.25% 56
2024
Q4
$849K Buy
7,502
+202
+3% +$23.3K 0.21% 68
2024
Q3
$832K Buy
7,300
+1,014
+16% +$111K 0.22% 74
2024
Q2
$653K Buy
6,286
+4,499
+252% +$477K 0.18% 81
2024
Q1
$203K Buy
+1,787
New +$205K 0.06% 148
2023
Q3
Sell
-2,026
Closed -$205K 100
2023
Q2
$205K Hold
2,026
0.08% 100
2023
Q1
$205K Buy
+2,026
New +$214K 0.08% 100
2022
Q4
Sell
-2,181
Closed -$211K 100
2022
Q3
$211K Buy
2,181
+252
+13% +$26.9K 0.1% 90
2022
Q2
$210K Buy
+1,929
New +$219K 0.1% 76

Other funds holding ABT

Auxano Advisors's ABT Position: Q1 2026 in Review

Auxano Advisors increased its Abbott (ABT) stake by 31% in Q1 2026, buying an estimated $261K and bringing the position to 9,841 shares worth $1.01M. The position accounts for 0.2% of the portfolio, ranked #79.

Auxano Advisors first reported a position in ABT in Q2 2022 and has held it in 13 quarters since. 3,085 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Auxano Advisors held 9,841 shares of Abbott worth $1.01M as of Q1 2026.
  • Auxano Advisors bought 2,314 Abbott shares in Q1 2026, an estimated $261K.
  • Abbott made up 0.2% of Auxano Advisors's portfolio in Q1 2026, its #79 holding.
  • Auxano Advisors first reported a position in Abbott in Q2 2022 and has held it in 13 quarters since.
  • 3,085 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Auxano Advisors's 13F filing for Q1 2026, filed 4 May 2026.